RARECELLS DIAGNOSTICS

The ISET® technology promises to improve the span and quality of life of patients with cancer. Such a highly sensitive technology will allow for a non-invasive, reliable and predictive diagnostic, which will bring remarkable help to people around the world in their struggle against cancer and save millions of lives through the early diagnosis of invasive cancers... The ISET® technology is the fruit of 20 years of research of Prof. Patrizia Paterlini-Bréchot and her team at the University Paris Descartes and INSERM (Institut National de la Santé et de la Recherche Médicale). Patrizia Paterlini-Bréchot is a Professor of Cellular and Molecular Biology at the University Paris Descartes in Paris, France and Hospital Practitioner at Assistance Publique-Hôpitaux de Paris. As an Oncologist and Hematologist, she and her team have studied cancer since 1982, and more specifically circulating tumor cells since 1995. The work of the team in fundamental and applied research led to the publication..

Also known as: Iset by Rarecells

Primary location: New York United States